Table of Contents

company-logo

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and TAK-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and Crohn's disease. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.

Finch Therapeutics Dividend Announcement

• Finch Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Finch Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Finch Therapeutics Dividend History

Finch Therapeutics Dividend Yield

Finch Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Finch Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Finch Therapeutics Financial Ratios

P/E ratio-1.34
PEG ratio-0.09
P/B ratio1.33
ROE-69.14%
Payout ratio0.00%
Current ratio3.87
Quick ratio3.87
Cash Ratio3.59

Finch Therapeutics Dividend FAQ

Does Finch Therapeutics stock pay dividends?
Finch Therapeutics does not currently pay dividends to its shareholders.
Has Finch Therapeutics ever paid a dividend?
No, Finch Therapeutics has no a history of paying dividends to its shareholders. Finch Therapeutics is not known for its dividend payments.
Why doesn't Finch Therapeutics pay dividends?
There are several potential reasons why Finch Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Finch Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Finch Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Finch Therapeutics a dividend aristocrat?
Finch Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Finch Therapeutics a dividend king?
Finch Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Finch Therapeutics a dividend stock?
No, Finch Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Finch Therapeutics stocks?
To buy Finch Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Finch Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.